TABLE OF CONTENT
1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. WHO SHOULD READ THIS REPORT
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1 SECONDARY RESEARCH
1.4.2 DATA ANALYSIS FRAMEWORK
1.4.3 MARKET SIZE ESTIMATION
1.4.4 FORECASTING
1.4.5 PRIMARY RESEARCH AND DATA VALIDATION
2. ANALGESICS MARKET – EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2021 - 2030, MILLION USD
3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1. INCREASING CHRONIC AND INFECTIOUS DISEASES AMONG PEOPLE
3.2.1.2. INCREASING NUMBER OF MEDICAL SURGERIES ACROSS THE WORLD
3.2.1.3. ELEVATING AWARENESS ABOUT PALLIATIVE CARE AND PAIN MANAGEMENT
3.2.2 RESTRAINTS
3.2.2.1. CHANGING REGULATORY LANDSCAPE IN THE MEDICAL DRUGS INDUSTRY
3.2.3 OPPORTUNITIES
3.2.3.1. INCREASING NUMBER OF STRATEGIC COLLABORATIONS AND ADVANCEMENTS IN MEDICAL DRUG DEVELOPMENT
4. GLOBAL ANALGESICS MARKET, BY TYPE
4.1. OVERVIEW
4.2. NON-OPIOID
4.2.1 NON-OPIOID MARKET, BY REGION
4.3. OPIOIDS
4.3.1 OPIOIDS MARKET, BY REGION
5. GLOBAL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
5.1. OVERVIEW
5.2. ORAL ROUTE
5.2.1 ORAL ROUTE MARKET, BY REGION
5.3. INTRAVENOUS ROUTE
5.3.1 INTRAVENOUS ROUTE MARKET, BY REGION
5.4. RECTAL ROUTE
5.4.1 RECTAL ROUTE MARKET, BY REGION
5.5. TRANSDERMAL ROUTE
5.5.1 TRANSDERMAL ROUTE MARKET, BY REGION
5.6. TOPICAL ROUTE
5.6.1 TOPICAL ROUTE MARKET, BY REGION
6. GLOBAL ANALGESICS BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1 NORTH AMERICA ANALGESICS MARKET, BY TYPE
6.2.2 NORTH AMERICA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.2.3 NORTH AMERICA ANALGESICS, BY COUNTRY
6.2.3.1. U.S.
6.2.3.1.1. U.S. ANALGESICS MARKET, BY TYPE
6.2.3.1.2. U.S. ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.2.3.2. CANADA
6.2.3.2.1. CANADA ANALGESICS MARKET, BY TYPE
6.2.3.2.2. CANADA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.2.3.3. MEXICO
6.2.3.3.1. MEXICO ANALGESICS MARKET, BY TYPE
6.2.3.3.2. MEXICO ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3. EUROPE
6.3.1 EUROPE ANALGESICS MARKET, BY TYPE
6.3.2 EUROPE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3 EUROPE ANALGESICS, BY COUNTRY
6.3.3.1. UK
6.3.3.1.1. UK ANALGESICS MARKET, BY TYPE
6.3.3.1.2. UK ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3.2. GERMANY
6.3.3.2.1. GERMANY ANALGESICS MARKET, BY TYPE
6.3.3.2.2. GERMANY ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3.3. SPAIN
6.3.3.3.1. SPAIN ANALGESICS MARKET, BY TYPE
6.3.3.3.2. SPAIN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3.4. SWEDEN
6.3.3.4.1. SWEDEN ANALGESICS MARKET, BY TYPE
6.3.3.4.2. SWEDEN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3.5. FRANCE
6.3.3.5.1. FRANCE ANALGESICS MARKET, BY TYPE
6.3.3.5.2. FRANCE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3.6. RUSSIA
6.3.3.6.1. RUSSIA ANALGESICS MARKET, BY TYPE
6.3.3.6.2. RUSSIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3.7. DENMARK
6.3.3.7.1. DENMARK ANALGESICS MARKET, BY TYPE
6.3.3.7.2. DENMARK ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.3.3.8. REST OF EUROPE
6.3.3.8.1. REST OF EUROPE ANALGESICS MARKET, BY TYPE
6.3.3.8.2. REST OF EUROPE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.4. ASIA-PACIFIC
6.4.1 ASIA-PACIFIC ANALGESICS MARKET, BY TYPE
6.4.2 ASIA-PACIFIC ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.4.3 ASIA-PACIFIC ANALGESICS, BY COUNTRY
6.4.3.1. JAPAN
6.4.3.1.1. JAPAN ANALGESICS MARKET, BY TYPE
6.4.3.1.2. JAPAN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.4.3.2. CHINA
6.4.3.2.1. CHINA ANALGESICS MARKET, BY TYPE
6.4.3.2.2. CHINA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.4.3.3. INDIA
6.4.3.3.1. INDIA ANALGESICS MARKET, BY TYPE
6.4.3.3.2. INDIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.4.3.4. AUSTRALIA
6.4.3.4.1. AUSTRALIA ANALGESICS MARKET, BY TYPE
6.4.3.4.2. AUSTRALIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.4.3.5. INDONESIA
6.4.3.5.1. INDONESIA ANALGESICS MARKET, BY TYPE
6.4.3.5.2. INDONESIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.4.3.6. REST OF ASIA-PACIFIC
6.4.3.6.1. REST OF ASIA-PACIFIC ANALGESICS MARKET, BY TYPE
6.4.3.6.2. REST OF ASIA-PACIFIC ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5. REST OF WORLD
6.5.1 REST OF WORLD ANALGESICS MARKET, BY TYPE
6.5.2 REST OF WORLD ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3 REST OF WORLD ANALGESICS, BY COUNTRY
6.5.3.1. BRAZIL
6.5.3.1.1. BRAZIL ANALGESICS MARKET, BY TYPE
6.5.3.1.2. BRAZIL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.2. VENEZUELA
6.5.3.2.1. VENEZUELA ANALGESICS MARKET, BY TYPE
6.5.3.2.2. VENEZUELA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.3. CHILE
6.5.3.3.1. CHILE ANALGESICS MARKET, BY TYPE
6.5.3.3.2. CHILE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.4. KINGDOM OF SAUDI ARABIA (KSA)
6.5.3.4.1. KINGDOM OF SAUDI ARABIA (KSA) ANALGESICS MARKET, BY TYPE
6.5.3.4.2. KINGDOM OF SAUDI ARABIA (KSA) ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.5. UAE
6.5.3.5.1. UAE ANALGESICS MARKET, BY TYPE
6.5.3.5.2. UAE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.6. MOROCCO
6.5.3.6.1. MOROCCO ANALGESICS MARKET, BY TYPE
6.5.3.6.2. MOROCCO ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.7. KENYA
6.5.3.7.1. KENYA ANALGESICS MARKET, BY TYPE
6.5.3.7.2. KENYA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.8. NIGERIA
6.5.3.8.1. NIGERIA ANALGESICS MARKET, BY TYPE
6.5.3.8.2. NIGERIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
6.5.3.9. REMAINING COUNTRIES
6.5.3.9.1. REMAINING COUNTRIES ANALGESICS MARKET, BY TYPE
6.5.3.9.2. REMAINING COUNTRIES ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1 COMPANY OVERVIEW
7.1.2 COMPANY SNAPSHOT
7.1.3 OPERATING BUSINESS SEGMENTS
7.1.4 PRODUCT PORTFOLIO
7.1.5 BUSINESS PERFORMANCE
7.1.6 SALES BY BUSINESS SEGMENT
7.1.7 SALES BY GEOGRAPHIC SEGMENT
7.1.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.1.9 PRIMARY MARKET COMPETITORS
7.2. BAYER AG
7.2.1 COMPANY OVERVIEW
7.2.2 COMPANY SNAPSHOT
7.2.3 OPERATING BUSINESS SEGMENTS
7.2.4 PRODUCT PORTFOLIO
7.2.5 BUSINESS PERFORMANCE
7.2.6 SALES BY BUSINESS SEGMENT
7.2.7 SALES BY GEOGRAPHIC SEGMENT
7.2.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.2.9 PRIMARY MARKET COMPETITORS
7.3. GLAXOSMITHKLINE PLC
7.3.1 COMPANY OVERVIEW
7.3.2 COMPANY SNAPSHOT
7.3.3 OPERATING BUSINESS SEGMENTS
7.3.4 PRODUCT PORTFOLIO
7.3.5 BUSINESS PERFORMANCE
7.3.6 SALES BY BUSINESS SEGMENT
7.3.7 SALES BY GEOGRAPHIC SEGMENT
7.3.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.3.9 PRIMARY MARKET COMPETITORS
7.4. JOHNSON & JOHNSON
7.4.1 COMPANY OVERVIEW
7.4.2 COMPANY SNAPSHOT
7.4.3 OPERATING BUSINESS SEGMENTS
7.4.4 PRODUCT PORTFOLIO
7.4.5 BUSINESS PERFORMANCE
7.4.6 SALES BY BUSINESS SEGMENT
7.4.7 SALES BY GEOGRAPHIC SEGMENT
7.4.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.4.9 PRIMARY MARKET COMPETITORS
7.5. NOVARTIS AG
7.5.1 COMPANY OVERVIEW
7.5.2 COMPANY SNAPSHOT
7.5.3 OPERATING BUSINESS SEGMENTS
7.5.4 PRODUCT PORTFOLIO
7.5.5 BUSINESS PERFORMANCE
7.5.6 SALES BY BUSINESS SEGMENT
7.5.7 SALES BY GEOGRAPHIC SEGMENT
7.5.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.5.9 PRIMARY MARKET COMPETITORS
7.6. PFIZER INC
7.6.1 COMPANY OVERVIEW
7.6.2 COMPANY SNAPSHOT
7.6.3 OPERATING BUSINESS SEGMENTS
7.6.4 PRODUCT PORTFOLIO
7.6.5 BUSINESS PERFORMANCE
7.6.6 SALES BY GEOGRAPHIC SEGMENT
7.6.7 SALES BY GEOGRAPHIC SEGMENT
7.6.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.6.9 PRIMARY MARKET COMPETITORS
7.7. SANOFI SA
7.7.1 COMPANY OVERVIEW
7.7.2 COMPANY SNAPSHOT
7.7.3 OPERATING BUSINESS SEGMENTS
7.7.4 PRODUCT PORTFOLIO
7.7.5 BUSINESS PERFORMANCE
7.7.6 SALES BY BUSINESS SEGMENT
7.7.7 SALES BY GEOGRAPHIC SEGMENT
7.7.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.7.9 PRIMARY MARKET COMPETITORS
7.8. TEVA PHARMACEUTICALS
7.8.1 COMPANY OVERVIEW
7.8.2 COMPANY SNAPSHOT
7.8.3 PRODUCT PORTFOLIO
7.8.4 BUSINESS PERFORMANCE
7.8.5 SALES BY GEOGRAPHIC SEGMENT
7.8.6 KEY STRATEGIC MOVES & DEVELOPMENTS
7.8.7 PRIMARY MARKET COMPETITORS
7.9. ABBVIE INC
7.9.1 COMPANY OVERVIEW
7.9.2 COMPANY SNAPSHOT
7.9.3 OPERATING BUSINESS SEGMENTS
7.9.4 PRODUCT PORTFOLIO
7.9.5 BUSINESS PERFORMANCE
7.9.6 SALES BY BUSINESS SEGMENT
7.9.7 SALES BY GEOGRAPHIC SEGMENT
7.9.8 KEY STRATEGIC MOVES & DEVELOPMENTS
7.9.9 PRIMARY MARKET COMPETITORS
7.10. SUN PHARMA
7.10.1 COMPANY OVERVIEW
7.10.2 COMPANY SNAPSHOT
7.10.3 PRODUCT PORTFOLIO
7.10.4 BUSINESS PERFORMANCE
7.10.5 SALES BY GEOGRAPHIC SEGMENT
7.10.6 KEY STRATEGIC MOVES & DEVELOPMENTS
7.10.7 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. GLOBAL ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 2. NON-OPIOID MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 3. OPIOIDS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 4. GLOBAL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 5. ORAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 6. INTRAVENOUS ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 7. RECTAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 8. TRANSDERMAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 9. TOPICAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 10. GLOBAL ANALGESICS BY REGION, 2021-2030, MILLION USD
TABLE 11. NORTH AMERICA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 12. NORTH AMERICA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 13. NORTH AMERICA ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
TABLE 14. U.S. ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 15. U.S. ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 16. CANADA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 17. CANADA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 18. MEXICO ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 19. MEXICO ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 20. EUROPE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 21. EUROPE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 22. EUROPE ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
TABLE 23. UK ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 24. UK ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 25. GERMANY ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 26. GERMANY ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 27. SPAIN ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 28. SPAIN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 29. SWEDEN ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 30. SWEDEN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 31. FRANCE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 32. FRANCE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 33. RUSSIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 34. RUSSIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 35. DENMARK ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 36. DENMARK ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 37. REST OF EUROPE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 38. REST OF EUROPE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 39. ASIA-PACIFIC ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 40. ASIA-PACIFIC ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 41. ASIA-PACIFIC ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
TABLE 42. JAPAN ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 43. JAPAN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 44. CHINA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 45. CHINA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 46. INDIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 47. INDIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 48. AUSTRALIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 49. AUSTRALIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 50. INDONESIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 51. INDONESIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 52. REST OF ASIA-PACIFIC ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 53. REST OF ASIA-PACIFIC ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 54. REST OF WORLD ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 55. REST OF WORLD ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 56. REST OF WORLD ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
TABLE 57. BRAZIL ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 58. BRAZIL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 59. VENEZUELA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 60. VENEZUELA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 61. CHILE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 62. CHILE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 63. KINGDOM OF SAUDI ARABIA (KSA) ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 64. KINGDOM OF SAUDI ARABIA (KSA) ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 65. UAE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 66. UAE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 67. MOROCCO ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 68. MOROCCO ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 69. KENYA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 70. KENYA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 71. NIGERIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 72. NIGERIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 73. REMAINING COUNTRIES ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 74. REMAINING COUNTRIES ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
TABLE 75. ABOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 76. ABOTT LABORATORIES: OPERATING SEGMENTS
TABLE 77. ABOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 78. ABOTT LABORATORIES: BUSINESS SEGMENT
TABLE 79. ABOTT LABORATORIES: GEOGRAPHIC SEGMENT
TABLE 80. ABOTT LABORATORIES: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 81. BAYER AG: COMPANY SNAPSHOT
TABLE 82. BAYER AG: OPERATING SEGMENTS
TABLE 83. BAYER AG: PRODUCT PORTFOLIO
TABLE 84. BAYER AG: BUSINESS SEGMENT
TABLE 85. BAYER AG: GEOGRAPHIC SEGMENT
TABLE 86. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 87. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 88. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 89. GLAXOSMITHKLINE PLC: BUSINESS SEGMENT
TABLE 90. GLAXOSMITHKLINE PLC: GEOGRAPHIC SEGMENT
TABLE 91. GLAXOSMITHKLINE PLC: KEY STRATEGIC MOVES & DEVELOPMENT
TABLE 92. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 93. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 94. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 95. JOHNSON & JOHNSON: BUSINESS SEGMENT
TABLE 96. JOHNSON & JOHNSON: GEOGRAPHIC SEGMENT
TABLE 97. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 98. NOVARTIS AG: OPERATING SEGMENTS
TABLE 99. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 100. NOVARTIS AG: BUSINESS SEGMENT
TABLE 101. NOVARTIS AG: GEOGRAPHIC SEGMENT
TABLE 102. NOVARTIS AG: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 103. PFIZER INC: COMPANY SNAPSHOT
TABLE 104. PFIZER INC.: OPERATING SEGMENTS
TABLE 105. PFIZER INC: PRODUCT PORTFOLIO
TABLE 106. PFIZER INC: BUSINESS SEGMENT
TABLE 107. PFIZER INC: GEOGRAPHIC SEGMENT
TABLE 108. PFIZER INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 109. SANOFI SA: COMPANY SNAPSHOT
TABLE 110. SANOFI SA: OPERATING SEGMENTS
TABLE 111. SANOFI SA: PRODUCT PORTFOLIO
TABLE 112. SANOFI SA: BUSINESS SEGMENT
TABLE 113. SANOFI SA: GEOGRAPHIC SEGMENT
TABLE 114. TEVA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 115. TEVA PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 116. TEVA PHARMACEUTICAL: GEOGRAPHIC SEGMENT
TABLE 117. ABBVIE INC: COMPANY SNAPSHOT
TABLE 118. ABBVIE INC: OPERATING SEGMENTS
TABLE 119. ABBVIE INC: PRODUCT PORTFOLIO
TABLE 120. ABBVIE INC: BUSINESS SEGMENT
TABLE 121. ABBVIE INC: GEOGRAPHIC SEGMENT
TABLE 122. ABBVIE INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 123. SUN PHARMA: COMPANY SNAPSHOT
TABLE 124. SUN PHARMA: PRODUCT PORTFOLIO
TABLE 125. SUN PHARMA: GEOGRAPHIC SEGMENT
TABLE 126. SUN PHARMA: KEY STRATEGIC MOVES & DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 2. NON-OPIOID MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 3. OPIOIDS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 4. GLOBAL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 5. ORAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 6. INTRAVENOUS ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 7. RECTAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 8. TRANSDERMAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 9. TOPICAL ROUTE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 10. GLOBAL ANALGESICS BY REGION, 2021-2030, MILLION USD
FIGURE 11. NORTH AMERICA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 12. NORTH AMERICA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 13. NORTH AMERICA ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 14. U.S. ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 15. U.S. ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 16. CANADA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 17. CANADA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 18. MEXICO ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 19. MEXICO ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 20. EUROPE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 21. EUROPE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 22. EUROPE ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 23. UK ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 24. UK ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 25. GERMANY ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 26. GERMANY ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 27. SPAIN ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 28. SPAIN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 29. SWEDEN ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 30. SWEDEN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 31. FRANCE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 32. FRANCE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 33. RUSSIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 34. RUSSIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 35. DENMARK ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 36. DENMARK ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 37. REST OF EUROPE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 38. REST OF EUROPE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 39. ASIA-PACIFIC ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 40. ASIA-PACIFIC ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 41. ASIA-PACIFIC ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 42. JAPAN ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 43. JAPAN ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 44. CHINA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 45. CHINA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 46. INDIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 47. INDIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 48. AUSTRALIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 49. AUSTRALIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 50. INDONESIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 51. INDONESIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 52. REST OF ASIA-PACIFIC ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 53. REST OF ASIA-PACIFIC ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 54. REST OF WORLD ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 55. REST OF WORLD ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 56. REST OF WORLD ANALGESICS, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 57. BRAZIL ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 58. BRAZIL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 59. VENEZUELA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 60. VENEZUELA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 61. CHILE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 62. CHILE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 63. KINGDOM OF SAUDI ARABIA (KSA) ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 64. KINGDOM OF SAUDI ARABIA (KSA) ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 65. UAE ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 66. UAE ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 67. MOROCCO ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 68. MOROCCO ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 69. KENYA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 70. KENYA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 71. NIGERIA ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 72. NIGERIA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 73. REMAINING COUNTRIES ANALGESICS MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 74. REMAINING COUNTRIES ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030, MILLION USD
FIGURE 75. ABOTT LABORATORIES: NET SALES, 2019–2021 ($MILLION)
FIGURE 76. ABOTT LABORATORIES: PRIMARY MARKET COMPETITORS
FIGURE 77. BAYER AG: NET SALES, 2019–2021 ($MILLION)
FIGURE 78. BAYER AG: PRIMARY MARKET COMPETITORS
FIGURE 79. GLAXOSMITHKLINE PLC: NET SALES, 2019–2021 ($MILLION)
FIGURE 80. GLAXOSMITHKLINE PLC: PRIMARY MARKET COMPETITORS
FIGURE 81. JOHNSON & JOHNSON, 2019–2021 ($MILLION)
FIGURE 82. JOHNSON & JOHNSON: PRIMARY MARKET COMPETITORS
FIGURE 83. NOVARTIS AG: NET SALES, 2019–2021 ($MILLION)
FIGURE 84. NOVARTIS AG: PRIMARY MARKET COMPETITORS
FIGURE 85. PFIZER INC: NET SALES, 2019–2021 ($MILLION)
FIGURE 86. PFIZER INC: PRIMARY MARKET COMPETITORS
FIGURE 87. SANOFI SA: NET SALES, 2019–2021 ($MILLION)
FIGURE 88. SANOFI SA: PRIMARY MARKET COMPETITORS
FIGURE 89. TEVA PHARMACEUTICALS: NET SALES, 2019–2021 ($MILLION)
FIGURE 90. TEVA PHARMACEUTICALS: PRIMARY MARKET COMPETITORS
FIGURE 91. ABBVIE INC: NET SALES, 2019–2021 ($MILLION)
FIGURE 92. ABBVIE INC: PRIMARY MARKET COMPETITORS
FIGURE 93. SUN PHARMA: NET SALES, 2019–2021 ($MILLION)
FIGURE 94. SUN PHARMA: PRIMARY MARKET COMPETITORS